BIOAFFINITY TECHNOLOGIES INC
BIAF · NASDAQ
Updated at 2026-10-14 09:34:49
- Today's High
- $3.74
- Today’s Low
- $3.23
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $4.75
- Previous Close
- $3.90
- Volume
- 284.99K
- Market Cap
- $4.54M
- P/E Ratio
- --
- EPS
- $-6.89
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- DIAGNOSTICS & RESEARCH
- Headquarters
- 3300 NACOGDOCHES ROAD, SAN ANTONIO, TX, UNITED STATES, 78217
- Country
- US
- Listing Date
- 2022-08-26
- Fiscal Year End
- December
- Shares Outstanding
- 7.78M
- CIK
- 0001712762
- Website
- bioaffinitytech.com
bioAffinity Technologies, Inc., a biotechnology company, is engaged in the development of non-invasive diagnostic tests and specific treatments for cancer. The company is headquartered in San Antonio, Texas.
Financial Metrics
Revenue
2026-06-30
$1.51M
2026-03-31
$1.35M
2025-12-31
$1.59M
2025-09-30
$1.44M
Operating Expenses
2026-06-30
$4.84M
2026-03-31
$3.92M
2025-12-31
$3.43M
2025-09-30
$2.68M
Net Income
2026-06-30
-$3.36M
2026-03-31
-$3.63M
2025-12-31
-$3.13M
2025-09-30
-$5.05M
Net Profit Margin
2026-06-30
-222.83%
2026-03-31
-268.63%
2025-12-31
-196.97%
2025-09-30
-349.29%
Earnings Per Share
2026-06-30
$-0.64
2026-03-31
$-0.81
2025-12-31
$-10.46
2025-09-30
$-4.74
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$3.29M
2026-03-31
-$3.5M
2025-12-31
-$2.99M
2025-09-30
-$4.92M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
-0.1%
2025-09-30
-0.06%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $1.51M | $1.35M | $1.59M | $1.44M |
| Operating Expenses | $4.84M | $3.92M | $3.43M | $2.68M |
| Net Income | -$3.36M | -$3.63M | -$3.13M | -$5.05M |
| Net Profit Margin | -222.83% | -268.63% | -196.97% | -349.29% |
| Earnings Per Share | $-0.64 | $-0.81 | $-10.46 | $-4.74 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$3.29M | -$3.5M | -$2.99M | -$4.92M |
| Effective Tax Rate | -- | -- | -0.1% | -0.06% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.